- Price is above the Trend Line, keeping the weekly tape constructive.
- Activity pressure is positive on the latest completed week.
- Volume is elevated versus the 13-week average, confirming attention.
603567
SHH
Week ended 07 Aug 2026
Weekly Investor Report
Heilongjiang ZBD Pharmaceutical Co., Ltd. · Healthcare · Drug Manufacturers - Specialty & Generic
Latest close
7.08 CNY
14.7%
latest week
Weekly setup
Mixed setup
The weekly trend is not active. Price is 1.3% above the Trend Line and sits at 31.3% of its 52-week range. The latest completed week returned 14.7%, after a 48.1% four-week move. The latest news-sentiment score is 50/100.
Setup score
44
out of 100
Latest Close
7.08 CNY
7 Aug 2026
1W Return
14.7%
latest completed week
4W Return
48.1%
short-term follow-through
12W Return
-2.7%
quarterly tape
Trend Breadth
25.0%
13 of 52 weeks active
Volume Ratio
2.2x
vs 13-week average
- The trend backdrop is inactive, so price action has not confirmed a constructive regime.
- Price is below Fair Value, so the market is still discounting the latest tape.
- Next-week expectancy is negative at 43.49% based on similar historical setup states.
- Activity pressure is weak, so confirmation is not yet broad enough.
- Trend Line remains the key weekly regime level.
- Activity pressure is the gauge to monitor for confirmation or fade.
- A volume ratio above 1.5x would show stronger participation in the next move.
Price follow-through
14.7%
Latest completed week; four-week move 48.1%.
Indicator stack
14/92
Trend and activity pressure are weighted against the latest 12-week confirmation window.
Trend backdrop
Active
The trend backdrop defines the current weekly regime.
Patient Capital
Recent
Activity-pressure buy-signal status for institutional accumulation timing.
Next-Week Expectancy
Negative 43.49%
Historical one-week expectancy contributes to the evidence score when direction is confirmed.
News sentiment
50/100
0 relevant articles in the latest sentiment read.
01 · Price action
Study the full chart
Where price is—and whether the trend supports it
The weekly trend is not active. Price is 1.3% above the Trend Line and sits at 31.3% of its 52-week range. The latest completed week returned 14.7%, after a 48.1% four-week move.
52-week price path
Price vs Trend Line and Fair Value
Price
Trend Line
Fair Value
02 · Volume and demand
Is real participation confirming the move?
Latest weekly volume is 2.2x the 13-week average. Participation is unusually strong and confirms that the move is attracting attention.
26-week volume confirmation
Bar height shows volume; colour shows the weekly price direction
6 Feb
13 Feb
27 Feb
6 Mar
13 Mar
20 Mar
27 Mar
3 Apr
10 Apr
17 Apr
24 Apr
1 May
8 May
15 May
22 May
29 May
5 Jun
12 Jun
19 Jun
26 Jun
3 Jul
10 Jul
17 Jul
24 Jul
31 Jul
7 Aug
Up week
Down week
Demand beneath price
Activity pressure and institutional-style signals
These indicators assess whether participation is improving beneath the headline price move. They are supporting evidence, not proof of institutional buying.
Activity pressure path
Latest 0.0912-week average 0.05
12-week confirmation
Trend active0/12Active trend-backdrop weeks in the latest 12-week window.
Positive pressure8/12Weeks with constructive activity pressure in the latest 12-week window.
Positive leadership0/12Weeks with positive relative leadership in the latest 12-week window.
Activity pressure0.09Current proprietary activity-pressure read.
Buy signals1Accumulation signal count in the latest 12 weeks.
Reversal markers0No reversal markers
No recent accumulation markers. No reversal markers.
03 · Momentum and leadership
Is performance persistent—and is the stock leading?
Performance is 48.1% over four weeks, -2.7% over 12 weeks, and -45.5% over one year. The current trend has remained active for 0 consecutive weeks.
Performance by holding period
Active trend streak0 weeks
Active weeks in one year13
Trend breadth25.0%
Activity pressure vs relative leadership
Activity pressureRelative leadership
Pressure1.02Latest activity-pressure read.
Pressure change299.1%Four-week change in activity pressure.
Leadership-19.19Latest relative-leadership reading.
RS change61.1%Four-week change in relative leadership.
04 · Fundamentals and valuation
Open full factor analysis
What investors are paying for—and the quality behind it
A published fundamentals and factor snapshot is not available for this company.
No published fundamental snapshot is available for this company.
05 · Ownership, options, and sentiment
What other market participants are doing
Options, insider transactions, market sentiment, and activity-pressure signals can confirm or challenge the price story. None should be used alone.
Insider activity-
No recent insider transactions are stored for this company.
News sentiment50/100
Weighted news tone is neutral across 0 relevant articles.
0 positive · 0 neutral · 0 negativePatient CapitalRecent
Activity-pressure buy-signal evidence highlights potential institutional accumulation windows.
Recent buy signal in the last 8 weeks
06 · Catalysts and risk
What can move the shares—and how volatile the path has been
Event timing, options-implied movement, drawdown, and weekly return distribution frame the risk around the current setup.
Next earnings-No event is currently stored.
Options expected move-Nearest-chain priced movement where available.
52-week drawdown-46.8%Distance below the 52-week high.
13-week volatility12.1%Standard deviation of weekly returns.
Weekly gains and losses
Latest 26 completed weeksEach bar is one week. Gains rise above the zero line; losses fall below it. Taller bars mean a larger weekly move.
6 Feb
13 Mar
10 Apr
8 May
5 Jun
3 Jul
7 Aug
Weeks higher10 of 2616 weeks finished lower.
Best week+26.2%Week of 17 Jul.
Worst week-22.0%Week of 19 Jun.
Latest week+14.7%Week of 7 Aug.
Shape of recent returns
Strong gains6
Modest gains4
Flat weeks0
Modest losses9
Sharp losses7
Recent vol12.1%13-week weekly-return volatility.
Base vol7.1%52-week weekly-return volatility.
Up/down split21/31Count of positive and negative weeks in the 52-week window.
Average skew4.9% / -4.9%Average positive week versus average negative week.
07 · Sector and peer context
Is this stock leading—or simply moving with its group?
Sector and industry breadth distinguish company-specific strength from a broad group move.
SectorCN Healthcare
4-week rank- / 100
Group average4.8%
Trend breadth21.0%
Trend21.0%active weekly trend signals
MD64.0%positive activity pressure
RS31.0%positive relative leadership
Four-week leaders
IndustryCN Drug Manufacturers - Specialty & Generic
4-week rank2 / 100
Group average5.1%
Trend breadth11.0%
Trend11.0%active weekly trend signals
MD69.0%positive activity pressure
RS18.0%positive relative leadership
Four-week leaders
08 · Evidence and weekly data
The underlying research record
Every top-level statement above should be traceable to a stored market, fundamental, event, or positioning observation.
Weekly tape34/100
Trend, activity pressure, participation, and risk combine to a 34/100 tape read.
Indicator analysis24/100Latest 12-week confirmation: trend 0/12, activity pressure 8/12, relative leadership 0/12.
Activity pressure 0.09; No reversal markers Next-Week ExpectancyNegative 43.49%Next-week expectancy is negative with a 43.49% historical one-week setup read.
Adds short-term historical context without overriding trend, activity, or relative leadership. Factors50/100No published factor snapshot is available yet.
Patient CapitalRecentActivity-pressure buy-signal evidence highlights potential institutional accumulation windows.
Recent buy signal in the last 8 weeks Sentiment50/100Weighted news tone is neutral across 0 relevant articles.
Insiders50/100No recent insider transaction evidence is stored.
Earnings50/100No stored earnings event is currently attached to this ticker.
| Week | Close | Return | Trend Line | Fair Value | Pressure | Leadership | Volume | Trend |
|---|---|---|---|---|---|---|---|---|
| 7 Aug 2026 | 7.08 CNY | 14.7% | 6.99 CNY | 10.55 CNY | 1.02 | -19.19 | 421.4M | Off |
| 31 Jul 2026 | 6.17 CNY | 5.5% | 7.05 CNY | 10.59 CNY | 0.63 | -28.73 | 560.0M | Off |
| 24 Jul 2026 | 5.85 CNY | -3.0% | 7.17 CNY | 10.64 CNY | 0.16 | -33.14 | 511.3M | Off |
| 17 Jul 2026 | 6.03 CNY | 26.2% | 7.30 CNY | 10.71 CNY | -0.29 | -31.11 | 278.9M | Off |
| 10 Jul 2026 | 4.78 CNY | -0.2% | 7.43 CNY | 10.76 CNY | -0.51 | -49.27 | 140.8M | Off |
| 3 Jul 2026 | 4.79 CNY | 11.9% | 7.61 CNY | 10.82 CNY | -0.56 | -50.64 | 36.4M | Off |
| 26 Jun 2026 | 4.28 CNY | -8.5% | 7.80 CNY | 10.89 CNY | -0.31 | -56.50 | 37.5M | Off |
| 19 Jun 2026 | 4.68 CNY | -22.0% | 8.00 CNY | 10.97 CNY | 0.16 | -53.98 | 147.6M | Off |
| 12 Jun 2026 | 6.00 CNY | -14.3% | 8.22 CNY | 11.04 CNY | 0.50 | -41.19 | 23.1M | Off |
| 5 Jun 2026 | 7.00 CNY | -2.1% | 8.41 CNY | 11.11 CNY | 0.74 | -32.25 | 18.6M | Off |
| 29 May 2026 | 7.15 CNY | -6.7% | 8.55 CNY | 11.17 CNY | 0.69 | -32.33 | 90.5M | Off |
| 22 May 2026 | 7.66 CNY | 5.2% | 8.71 CNY | 11.23 CNY | 0.38 | -29.11 | 105.1M | Off |
| 15 May 2026 | 7.28 CNY | 0.3% | 8.85 CNY | 11.28 CNY | -0.39 | -33.69 | 92.5M | Off |
| 8 May 2026 | 7.26 CNY | 2.5% | 9.01 CNY | 11.34 CNY | -0.87 | -35.31 | 48.5M | Off |
How to use this report
This is a completed-week research summary. It explains the available evidence and its conflicts; it does not predict a guaranteed outcome or replace your own risk assessment. Fundamental figures may refer to an earlier financial reporting period, which is shown above.